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C A S E  R E P O R T
A 67-year-old woman with a bileaflet mitral valve prosthesis since 2007 due to 
mitral stenosis and chronic atrial fibrillation was admitted because of severe short-
ness of breath and diarrhea. She had been discharged from the hospital one week 
earlier on clarithromycin due to lower respiratory tract infection. She gave a history 
of increasing shortness of breath on exertion ever since, with the recent addition of 
diarrhea over the last 24 hours. Her past medical history includes previous ischemic 
stroke in 2004.
On clinical examination the prosthetic first heart sound was reduced in intensity 
and on auscultation of the lungs she had coarse crepitations bilaterally and bronchial 
breathing over the left lower lung field. Performed chest X-ray revealed consolidation 
of the left lower lobe and bilateral pleural effusion. Her ECG demonstrated atrial 
fibrillation with a rate of 90 bpm and the arterial blood gas indicted mild metabolic 
acidosis (PH= 7.33, HCO3= 19 mEq/lt, pO2= 85 mmHg, and pCO2= 40 mmHg). 
White cell count and C-reactive protein were increased as expected and INR was 1.5. 
Patient was immediately started on unfractionated heparin. Bedside transthoracic 
echocardiogram revealed increased velocities across the prosthetic mitral valve (MV 
peak vel= 2.8 m/s, peak gradient= 35 mmHg, mean gradient= 25 mmHg) (Figure 
1). Patient deteriorated significantly despite an adequate anticoagulation achieved 
within 6 hours. Transesophageal echocardiography with live 3D was performed which 
confirmed the presence of a thrombus on the atrial side of the prosthetic valve result-
ing in an immobile lateral leaflet and a severely restricted anterior leaflet (Figures 2 
& 3). Furthermore there was a large thrombus in the left atrial appendage extending 
into the left atrium.
Patient underwent urgent redo mitral valve replacement. The mitral valve prosthesis 
was severely covered with thrombus and the cusps were fixed. A bioprosthetic St Jude 
medical mitral valve was implanted with good results.
D I S C U S S I O N
Prosthetic heart valve thrombosis with obstruction remains a significant problem 
causing increased morbidity and mortality. It occurs in 1% to 3% of cases annually 
which is somewhat lower than the annual risk of bleeding due to anticoagulation therapy 
(2.7%)1. According to the recent guidelines2, in hemodynamically unstable patients 
immediate action is warranted and surgical treatment is preferred over thrombolysis 
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when readily available or there are no serious contraindica-
tions or comorbidities precluding its use. Moreover, in the 
presence of thrombus in the left atrial appendage, as in this 
case, thrombolysis adds to the risk of systematic embolization3. 
A repeat operation carries a significant risk, with mortality 
rate ranging between 10-15%, which may be two- or three- fold 
higher in critically ill patients4. The single most important 
risk factor that contributes to prosthetic valve thrombosis is 
inadequate anticoagulation, followed by the position of the 
prosthesis, mitral being more thrombogenic than aortic, the 
type of the prosthetic valve, presence of atrial fibrillation, low 
cardiac output and hypercoagulable states such as pregnancy, 
dehydration or inflammation.
Recent history of increasing shortness of breath or an 
embolic event along with findings on clinical examination 
such as reduced intensity of first prosthetic heart sound or 
its absence should alert the clinician towards the possibility 
of prosthetic mitral valve thrombosis. Suboptimal INR and 
transthoracic or transesophageal echocardiograms confirm 
the diagnosis.
It may be possible to demonstrate the type of mitral pros-
thesis as well as the restricted motion of disks or occluder from 
a transthoracic approach but Doppler echocardiography is 
more important since it can define the increased transmitral 
peak and mean gradient as well as the pressure half time 
(PHT) and mitral valve area with PHT. Prosthetic obstruction 
considerably prolongs the PHT, and this may be a very useful 
sign especially if the image quality is not good. A PHT longer 
than 200 ms is unusual in a normal functioning prosthetic 
valve especially when peak velocity is above 2.5 m/sec.5 A 
transesophageal echo (TEE) study allows better visualization 
of the prosthetic valve and its motion throughout the cardiac 
cycle and defines whether it is restricted or not. Masses at-
tached to the valve or the ring are relatively easily defined 
as well as their size and extent in the left atrium. TEE also 
allows the differential diagnosis between thrombus and pan-
nus formation based on the size and the echogenicity, thrombi 
are usually larger, extend into the left atrium and have a soft 
echodensity similar to that of the myocardium6. Furthermore, 
live 3-D TEE offers the opportunity to inspect the atrial size 
of the prosthesis allowing a comprehensive assessment of the 
size and nature of attached masses and a direct high quality 
‘surgical’ view of the prosthesis.
FIGURE 2. Transoesophageal study. Immobile lateral disk and 
restricted opening of the anterior disk resulting in highly turbu-
lent flow across the valve during colour flow mapping.
FIGURE 1. Transthoracic study, continuous wave LV inflow. 
Peak transmitral velocity is 2.8 m/s, peak gradient is 36 mmHg 
and mean gradient 26 mmHg, indicating severe stenosis of the 
prosthetic valve.
FIGURE 3. 3D transesophageal echo (TEE) study picture of the 
atrial side of the mitral prosthesis in diastole. The valve barely 
opens (see arrow).
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